Back

Putative Role of Norrin in Neuroretinal Differentiation Revealed by bulk and scRNA Sequencing of Human Retinal Organoids

Maggi, K.; Atac, D.; Maggi, J.; Feil, S.; Koller, S.; Berger, W.

2024-11-15 neuroscience
10.1101/2024.11.15.623746 bioRxiv
Show abstract

Pathogenic variants in the X-linked gene NDP (Norrie disease protein) have been associated with a variety of non-syndromic and syndromic human retinal diseases, including Norrie disease and familial exudative vitroretinopathy. The gene codes for Norrin, a secreted angiogenic molecule which binds to FZD4 and its co-receptors LRP5/6 and TSPAN12 and activates Wnt-signaling. Additionally, it also potentiates Wnt-signaling by binding to the LGR4 receptor. Norrin was also found to exert a neuroprotective function in the retina, specifically for retinal ganglion cells. Furthermore, it was suggested to be involved in neurodevelopmental processes such as early neuro-ectodermal specification and differentiation, as well as maintenance of cochlear hair cells. To better understand the putative role of Norrin in neuronal cells of the retina we generated NDP mutant and eGFP-expressing NDP reporter human induced pluripotent stem cells, which were differentiated to retinal organoids. Bulk RNA sequencing and fixed single-cell RNA sequencing revealed alterations in gene expression as well as cellular composition, with increased proportions of retinal progenitors as well as Muller glia cells in NDPKO retinal organoids. Differential expression of genes related to glutamate signaling, Wnt and MAPK signaling, as well as neurogenesis was detected. Furthermore, genes associated with functions in the extracellular matrix were also differentially expressed. The considerable decrease in retinal neurons found in our NDPKO organoids suggest that Norrin is also important for retinal neurogenesis, which may precede the vascular manifestations in NDP-associated diseases.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 1%
17.4%
2
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.1%
12.3%
3
Cell Death & Disease
126 papers in training set
Top 0.1%
6.8%
4
International Journal of Molecular Sciences
453 papers in training set
Top 0.9%
6.3%
5
Human Molecular Genetics
130 papers in training set
Top 0.5%
4.8%
6
Investigative Ophthalmology & Visual Science
22 papers in training set
Top 0.1%
2.6%
50% of probability mass above
7
Disease Models & Mechanisms
119 papers in training set
Top 0.7%
2.4%
8
BMC Medical Genomics
36 papers in training set
Top 0.4%
1.9%
9
Neurobiology of Disease
134 papers in training set
Top 2%
1.9%
10
Acta Neuropathologica Communications
81 papers in training set
Top 0.5%
1.9%
11
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.4%
1.7%
12
npj Genomic Medicine
33 papers in training set
Top 0.4%
1.7%
13
Nature Communications
4913 papers in training set
Top 51%
1.7%
14
Cells
232 papers in training set
Top 3%
1.7%
15
Stem Cell Reports
118 papers in training set
Top 0.6%
1.3%
16
eLife
5422 papers in training set
Top 47%
1.3%
17
Experimental Eye Research
30 papers in training set
Top 0.4%
1.2%
18
PLOS ONE
4510 papers in training set
Top 60%
1.2%
19
Frontiers in Neuroscience
223 papers in training set
Top 6%
0.9%
20
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
21
Communications Biology
886 papers in training set
Top 17%
0.9%
22
Biomolecules
95 papers in training set
Top 1%
0.9%
23
Translational Vision Science & Technology
35 papers in training set
Top 0.5%
0.9%
24
iScience
1063 papers in training set
Top 33%
0.7%
25
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 9%
0.7%
26
Clinical and Translational Science
21 papers in training set
Top 1%
0.7%
27
Molecular Therapy
71 papers in training set
Top 3%
0.7%
28
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.8%
0.7%
29
Brain
154 papers in training set
Top 5%
0.7%
30
Open Biology
95 papers in training set
Top 3%
0.6%